101 related articles for article (PubMed ID: 29454423)
1. Statement of Concern Regarding: Sato Y, Iwamoto J, Kanoko T, Satoh K. Homocysteine as a Predictive Factor for Hip Fracture in Elderly Women with Parkinson's Disease. Am J Med. 2005;118:1250-1255.
Alpert JS
Am J Med; 2018 Mar; 131(3):e109. PubMed ID: 29454423
[No Abstract] [Full Text] [Related]
2. Retraction: 'Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke' by J. Iwamoto, T. Takeda and H. Matsumoto.
Acta Neurol Scand; 2018 Jun; 137(6):630. PubMed ID: 29732540
[TBL] [Abstract][Full Text] [Related]
3. Retraction: 'Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: A randomized controlled trial,' by Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, K.
Mov Disord; 2016 Jul; 31(7):1077. PubMed ID: 27374761
[TBL] [Abstract][Full Text] [Related]
4. Retraction: 'Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients,' by Sato Y., Honda Y., Iwamoto, J., Kanoko, T., and Satoh, K.
Mov Disord; 2019 Jan; 34(1):156. PubMed ID: 30653727
[No Abstract] [Full Text] [Related]
5. Dementia predicted one-year mortality for patients with first hip fracture: a population-based study.
Chiu HC; Chen CM; Su TY; Chen CH; Hsieh HM; Hsieh CP; Shen DL
Bone Joint J; 2018 Sep; 100-B(9):1220-1226. PubMed ID: 30168771
[TBL] [Abstract][Full Text] [Related]
6. Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study.
Gjesdal CG; Vollset SE; Ueland PM; Refsum H; Meyer HE; Tell GS
J Bone Miner Res; 2007 May; 22(5):747-56. PubMed ID: 17295607
[TBL] [Abstract][Full Text] [Related]
7. Rehabilitation of hip fracture patients with Parkinson's Disease.
Jónsson B; Sernbo I; Johnell O
Scand J Rehabil Med; 1995 Dec; 27(4):227-30. PubMed ID: 8650507
[TBL] [Abstract][Full Text] [Related]
8. Hip fractures and Parkinson's disease: A case series.
Coomber R; Alshameeri Z; Masia AF; Mela F; Parker MJ
Injury; 2017 Dec; 48(12):2730-2735. PubMed ID: 28985911
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine as a predictive factor for hip fracture in older persons.
McLean RR; Jacques PF; Selhub J; Tucker KL; Samelson EJ; Broe KE; Hannan MT; Cupples LA; Kiel DP
N Engl J Med; 2004 May; 350(20):2042-9. PubMed ID: 15141042
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine as a predictive factor for hip fracture in stroke patients.
Sato Y; Honda Y; Iwamoto J; Kanoko T; Satoh K
Bone; 2005 Apr; 36(4):721-6. PubMed ID: 15781007
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease and risk of hip fracture: systematic review and meta-analysis.
Hosseinzadeh A; Khalili M; Sedighi B; Iranpour S; Haghdoost AA
Acta Neurol Belg; 2018 Jun; 118(2):201-210. PubMed ID: 29767373
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease.
Sato Y; Manabe S; Kuno H; Oizumi K
J Neurol Neurosurg Psychiatry; 1999 Jan; 66(1):64-8. PubMed ID: 9886454
[TBL] [Abstract][Full Text] [Related]
13. Occurrence, management and outcomes of hip fractures in patients with Parkinson's disease.
Critchley RJ; Khan SK; Yarnall AJ; Parker MJ; Deehan DJ
Br Med Bull; 2015 Sep; 115(1):135-42. PubMed ID: 26130734
[TBL] [Abstract][Full Text] [Related]
14. Assessment of risk factors for second hip fractures in Japanese elderly.
Yamanashi A; Yamazaki K; Kanamori M; Mochizuki K; Okamoto S; Koide Y; Kin K; Nagano A
Osteoporos Int; 2005 Oct; 16(10):1239-46. PubMed ID: 15729479
[TBL] [Abstract][Full Text] [Related]
15. [Immobilization and hip fracture].
Sato Y
Clin Calcium; 2006 Dec; 16(12):1991-98. PubMed ID: 17142929
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of prosthesis survival after primary hip arthroplasty in elderly patients with Parkinson's syndrome].
Hunag J; Xia H; Chen Y; Liu Z; Chen X; Wang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 May; 44(5):555-561. PubMed ID: 31303620
[TBL] [Abstract][Full Text] [Related]
17. Hip fractures in patients with Parkinson's disease.
Coughlin L; Templeton J
Clin Orthop Relat Res; 1980 May; (148):192-5. PubMed ID: 7379394
[TBL] [Abstract][Full Text] [Related]
18. Article retraction. Sato Y, Honda Y, Iwamoto J, Amano N. Comparison of non-vertebral fracture between minodronate and risedronate therapy in elderly female patients with Alzheimer disease. J Musculoskelet Neuronal Interact 2013;13:346-52.
J Musculoskelet Neuronal Interact; 2016 Sep; 16(3):264. PubMed ID: 27609042
[No Abstract] [Full Text] [Related]
19. Is there an increased risk of hip fracture in Parkinson's disease? A nationwide inpatient sample.
Bhattacharya RK; Dubinsky RM; Lai SM; Dubinsky H
Mov Disord; 2012 Sep; 27(11):1440-3. PubMed ID: 22744727
[TBL] [Abstract][Full Text] [Related]
20. [Gait in patients with Parkinson's disease after surgically treated hip fracture].
Gialanella B
Minerva Med; 2001 Jun; 92(3):161-6. PubMed ID: 11404725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
